On Aug. 27, 2025, the U.S. Food and Drug Administration (FDA) limited approval for updated COVID-19 vaccines to all people 65 years and older and people under 65 years with underlying medical conditions. At the same time, the Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP) has not yet issued recommendations for the updated COVID-19 vaccine – while CDC already moved COVID-19 from the list of shots recommended for all healthy kids and pregnant women to a recommendation to have a discussion with your provider about benefits versus risks of getting the shot. As a result, some providers and pharmacies were reluctant to stock updated COVID-19 vaccines. Many pharmacies who had updated stock were requiring either a prescription or an attestation of underlying medical conditions for vaccination. These delays were due to inaction by the ACIP over the summer. The ACIP recommendations in the past have formed the basis of the protocols in Oregon for pharmacists to administer vaccines. What this meant was that families were confused, providers were under pressure, pharmacies were underresourced, and communities have been left more vulnerable.